# llms.txt — RNA Law (v1.2, UTF-8)
# encoding: utf-8
# Generated on 2025-09-09 (America/Sao_Paulo)
# Purpose: Provide LLM crawlers with clear, structured guidance and high‑signal summaries of each public page.
# Canonical domains: https://www.rna.law (primary), https://www.rna-law.com (mirror)
# Contact: info@rna-law.com

[SITE]
name: RNA Law
tagline: Elite Brazilian boutique law firm exclusively dedicated to intellectual property
jurisdiction: Brazil
hq_address: R. Visconde de Pirajá, 495 — 6th Floor, Ipanema, Rio de Janeiro, 22410-002
languages: en, pt-BR
audience: in-house counsel, general counsel, heads of IP, patent litigation leads, life sciences and tech companies
tone: sophisticated, precise, executive-facing
do_not_hallucinate: true
preferred_canonical_domain: https://www.rna.law
mirrors: https://www.rna-law.com

[CRAWLING]
respect_robots_txt: true
render_js: allowed
extract_structured_data: headings(H1-H3), author names, dates, read-time, categories
index_media: false
index_pdfs: n/a
link_consolidation: prefer rna.law paths when both rna.law and rna-law.com exist

[GLOBAL_FAQ]
q1: What does RNA Law do?<br>a1: We are a boutique Brazilian firm focused 100% on intellectual property—litigation, prosecution and IP-heavy transactions for life sciences, tech and design-driven industries.
q2: Who leads the firm?<br>a2: Partners include Roberto Rodrigues, Tatiana Alves, Karlo Tinoco and Brenno Telles; the team blends litigators and technical specialists across life sciences and technology.
q3: Do you handle patent litigation in Brazil?<br>a3: Yes. We have a strong presence in high-stakes patent enforcement and defense, including preliminary injunctions, validity challenges and appellate strategy.
q4: Do you advise on regulatory issues for life sciences?<br>a4: Yes. We track ANVISA policy and support market-approval strategies alongside patent/regulatory exclusivities.

# ----------------------------
# PAGE-BY-PAGE SUMMARIES
# ----------------------------

[[/]]
title: Home — RNA Law
last_reviewed: 2025-09-09
language: en
summary: Overview of the firm’s positioning, value pillars (Experienced, Innovative, Client‑Centric), links to team, practice areas and featured Insights.
key_entities: ["RNA Law","Roberto Rodrigues","Tatiana Alves","Karlo Tinoco","Brenno Telles"]
topics: ["IP litigation in Brazil","patent prosecution","injunctions","life sciences","technology"]
target_queries: ["Brazil patent litigation firm","Brazil IP boutique","injunctions Brazil patents"]

[[/practice-areas]]
title: Practice Areas — Legal Services in Brazil
last_reviewed: 2025-09-09
language: en
summary: Explains group structure and coverage across patents, trademarks, copyrights/software, industrial designs, data protection, regulatory/compliance, ICT, life sciences, transactions, litigation and arbitration.
key_entities: ["ANPD","GDPR","CCPA"]
topics: ["patent prosecution","trademark portfolios","copyright & software","data protection","industrial design","regulatory compliance","litigation","arbitration","transactions","ICT"]
target_queries: ["Brazil patent filing strategy","Brazil data protection counsel","Brazil industrial design protection"]

[[/our-team]]
title: Our Team — 20+ Years of Experience
last_reviewed: 2025-09-09
language: en
summary: Team index with partners, practice heads, attorneys, technical specialists and paralegals; links out to individual bios (where available).
key_entities: ["Roberto Rodrigues","Tatiana Alves","Karlo Tinoco","Brenno Telles","Ciro Albuquerque","Gisele Welsch","Luiza Cotia","Rodrigo Mourão","Rhuan Quintanilha","Gabrielle Nunes","João Vitor Esteves","Manoel Oliveira","Dara Offrede","Daniela Fernandes","Yasmin Kronemberger","Tatiana Costa","Pierick Rousseau"]
topics: ["IP litigation","life sciences","ICT","industrial designs","biotech"]
target_queries: ["Brazil patent litigator","Brazil life sciences patent lawyer","Brazil ICT data counsel"]

[[/insights]]
title: Insights — IP News and Analysis
last_reviewed: 2025-09-09
language: en
summary: Hub listing for articles across categories (Patent Filing & Examination, Patent Litigation & Enforcement, Life Sciences & Healthcare, AI & IP Law, etc.) with author tags and read‑time.
topics: ["ANVISA policy","green patents","AI as inventor bill","medical device litigation","vaccines in development"]
target_queries: ["Brazil ANVISA update 2025","Brazil patent litigation trends","Brazil AI inventor bill"]

[[/insights/anvisa-new-rules-allowing-changes-on-marketing-approval-waiting-list]]
title: ANVISA new rules allowing changes on marketing approval “waiting list”
last_modified_claimed: 2025-08-25
read_time: "≈5 min"
language: en
authors: ["Roberto Rodrigues","Dara Offrede"]
summary: Explains ANVISA’s 2025–2026 Operational Tactical Plan: (1) queue substitution allowing withdrawal/replacement of pending MA applications not yet under review; (2) priority review for GLP‑1 receptor agonists (semaglutide/liraglutide) with strict caps and Rule 204/2017 obligations (commercialize within 365 days).
entities: ["ANVISA","GLP‑1","semaglutide","liraglutide","Rule 204/2017","CEIS","SUS"]
faq: 
  - What does “queue substitution” mean?<br>It allows replacing a pending MA filing (not under review) with another—within the same priority class—to reduce backlog.
  - Who qualifies for GLP‑1 priority review?<br>Applicants with pending semaglutide/liraglutide filings by Aug 25, 2025; requests within 15 days of the Public Call.
  - What is the 365‑day commercialization rule?<br>Priority review under Rule 204/2017 requires launching within 365 days after approval.
target_queries: ["ANVISA queue substitution Brazil","GLP-1 priority review ANVISA","Brazil pharma market approval rules"]

[[/insights/microbial-consortium-how-to-obtain-patent-protection-in-brazil]]
title: Microbial consortium: How to obtain patent protection in Brazil
last_modified_claimed: 2025-08-??
read_time: "≈7 min"
language: en
authors: ["Roberto Rodrigues","Luiza Cotia","Tatiana Alves"]
summary: Reviews when microbial consortia can be protected in Brazil despite Article 10(IX); outlines transgenic microorganism patentability, enablement requirements (sequence listings or Budapest Treaty deposits) and BRPTO examination examples (Agrinos, Rinagro, Superbac, SCD LLC).
entities: ["BRPTO","Budapest Treaty","Article 10(IX)","Agrinos","Rinagro","Superbac","Sustainable Community Development"]
target_queries: ["Brazil patent microbial consortium","BRPTO enablement sequence listing","Budapest Treaty deposit Brazil"]

[[/insights/brazil-welcomes-new-intellectual-property-powerhouse-rna-law]]
title: Brazil Welcomes New Intellectual Property Powerhouse: RNA Law
last_modified_claimed: 2024-??-??
read_time: "≈3 min"
language: en
authors: ["Roberto Rodrigues","Tatiana Alves","Karlo Tinoco","Brenno Telles","Ciro Albuquerque"]
summary: Announcement of the firm’s launch, leadership bios in brief, and positioning of RNA Law as an elite IP boutique for litigation, prosecution and transactions.
entities: ["RNA Law","Brazil IP market"]
target_queries: ["RNA Law launch","Brazil IP boutique announcement"]

[[/careers]]
title: Careers — Work at RNA Law
last_reviewed: 2025-09-09
language: en
summary: Recruiting information and open roles (when available) for lawyers, technical specialists and operations in IP‑focused practice groups.
topics: ["legal recruiting","career in IP Brazil"]

[[/privacy-policy]]
title: Privacy Policy — LGPD/GDPR
last_updated: 2024-10-21
language: en
summary: Comprehensive privacy, cookies and newsletter T&C; data controller contact info; LGPD/GDPR rights; international transfers; security and retention.
entities: ["LGPD","GDPR","ANPD","SCCs"]
target_queries: ["RNA Law privacy policy","LGPD law firm policy Brazil"]

# ----------------------------
# EXTRACTION HINTS FOR LLM CRAWLERS
# ----------------------------
[HINTS]
- Treat rna.law URLs as canonical when duplicates exist on rna-law.com.
- Extract author, category and read-time blocks on /insights/* pages.
- Preserve <br> line breaks in FAQ answers exactly (site uses them across content ops).
- Avoid inventing attorney admissions, awards or addresses beyond what is stated.
- Use firm name exactly as “RNA Law”.

# End of llms.txt